Loading chat...

WA HB2113

Bill

Status

Passed

3/9/2026

Primary Sponsor

Andrew Engell

Click for details

Origin

House of Representatives

2025-2026 Regular Session

AI Summary

  • Amends supervision requirements for diagnostic radiologic technologists, therapeutic radiologic technologists, and magnetic resonance imaging technologists performing parenteral procedures related to radiologic technology

  • Allows intravenous contrast procedures to be performed under "virtual direct supervision" via real-time interactive audio and video technology (excluding audio-only) by a licensed physician

  • Expands who can directly supervise intravenous contrast procedures to include physicians, advanced practice registered nurses, and physician assistants

  • Requires clinical staff with training to respond to adverse events be present on-site at the facility before technologists may administer intravenous contrast agents

  • Removes previous language requiring direct physician supervision for all parenteral procedures, creating a more flexible supervision framework

Legislative Description

Concerning the supervision of diagnostic radiologic technologists, therapeutic radiologic technologists, and magnetic resonance imaging technologists.

Last Action

Effective date 6/11/2026.

3/9/2026

Committee Referrals

Rules2/25/2026
Health & Long-term Care2/18/2026
Rules1/26/2026
Health Care and Wellness1/12/2026

Full Bill Text

No bill text available